Multiomics Enhances Drug Target Discovery by Revealing Therapeutic Vulnerabilities

Multiomics Enhances Drug Target Discovery by Revealing Therapeutic Vulnerabilities

Audio narration · Coming soon

This article discusses how multiomics approaches can aid researchers in identifying more promising drug targets. Dr. Shi-qi An explains that combining molecular data helps uncover therapeutic vulnerabilities and mechanisms of drug resistance, potentially improving drug development strategies.

Why this matters

PRISM scored this story 60/100 for interest.

Originally published by gnews